Peter van der Ley

6.8k citations

127 papers · 5.3k indexed · h-index 41

Impact in

Microbiology top 0.02%
- Bacterial Infections and Vaccines
Endocrinology top 0.5%
- Escherichia coli research studies

Papers in

Microbiology 90
- Bacterial Infections and Vaccines 89
Immunology 51
- Immune Response and Inflammation 45

Co-authors: Jan Tommassen Jan Poolman Liana Steeghs Leo van der Pol Michiel Stork Betsy Kuipers Loek van Alphen Jan ten Hove
Journals: Infection and Immunity (22 papers)Vaccine (18 papers)Journal of Biological Chemistry (7 papers)Molecular Microbiology (7 papers)Cellular Microbiology (5 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Peter van der Ley

126 papers receiving 5.1k citations

Peers

Countries citing papers authored by Peter van der Ley

Since Specialization

Citations

This map shows the geographic impact of Peter van der Ley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter van der Ley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter van der Ley more than expected).

Fields of papers citing papers by Peter van der Ley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter van der Ley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter van der Ley. The network helps show where Peter van der Ley may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter van der Ley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter van der Ley Line = papers co-authored together Peter van der Ley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A novel cable bacteria species with a distinct morphology and genomic potential Applied and Environmental Microbiology ·钟嘉陵, Peter van der Ley, Pritpal Aujla, Cheng Li, Dmitry Pankratov, 卓岡部, Galina Pankratova, Jeanine S. Geelhoed, Diana Vasquez‐Cardenas, Clare E. Reimers, Filip J. R. Meysman	2025	0
2	Cable bacteria colonise new sediment environments through water column dispersal Environmental Microbiology ·Pritpal Aujla, Jeanine S. Geelhoed, Peter van der Ley, Silvia Hidalgo‐Martinez, Miguel Portillo‐Estrada, Erik Verbruggen, Filip J. R. Meysman	2024	3
3	On the diversity, phylogeny and biogeography of cable bacteria Frontiers in Microbiology ·Peter van der Ley, Jeanine S. Geelhoed, Diana Vasquez‐Cardenas, Filip J. R. Meysman	2024	4
4	Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteria PubMed ·Sukumar Saha, Elder Pupo, K. Tangtartharakul, Peter van der Ley	2022	15
5	Nanoflow LC–MS Method Allowing In-Depth Characterization of Natural Heterogeneity of Complex Bacterial Lipopolysaccharides Analytical Chemistry ·Elder Pupo, Peter van der Ley, Hugo D. Meiring	2021	11
6	Substrate specificity of the pyrophosphohydrolase LpxH determines the asymmetry of Bordetella pertussis lipid A Journal of Biological Chemistry ·Jesús Arenas, Elder Pupo, 何娅妮, Dennys Patricia Jordán Correa, Jörg Schaarschmidt, Peter van der Ley, Jan Tommassen	2019	5
7	Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response Infection and Immunity ·K. Tangtartharakul, 동호 김, Bas van de Waterbeemd, Hendrik Jan Hamstra, Mohsen Shafie Seifabadi, Elly van Riet, Jos P. M. van Putten, Peter van der Ley	2016	46
8	Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide Scientific Reports ·K. Tangtartharakul, Elder Pupo, Elly van Riet, Jos P. M. van Putten, Peter van der Ley	2016	24
9	Outer membrane vesicles as platform vaccine technology Biotechnology Journal ·Leo van der Pol, Michiel Stork, Peter van der Ley	2015	282
10	Biosynthetically engineered lipopolysaccharide as vaccine adjuvant Expert Review of Vaccines ·K. Tangtartharakul, Peter van der Ley	2015	51
11	Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains Vaccine ·Janny Westdijk, Kitagawa Kazumaro, Mario Barro, 大島伸介, Nicolas Collin, Thomas S. Vedvick, Wilfried A.M. Bakker, Peter van der Ley, Gideon Kersten	2013	34
12	Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles Vaccine ·K. Tangtartharakul, Harry van Dijken, Hendrik-Jan Hamstra, Michiel van der Flier, Gestur Vidarsson, Jos P. M. van Putten, Claire J. P. Boog, Germie van den Dobbelsteen, Peter van der Ley	2013	11
13	Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine PLoS ONE ·Manish Sadarangani, M Mohamdi Niko, Martin Callaghan, Claire Jones, Hannah Chan, Katherine Makepeace, Hugh Dubberly, Mary E. Deadman, Christopher D. Bayliss, Ian M. Feavers, Peter van der Ley, Andrew J. Pollard	2012	7
14	Next-generation outer membrane vesicle vaccines againstNeisseria meningitidisbased on nontoxic LPS mutants Human Vaccines ·Peter van der Ley, Germie van den Dobbelsteen	2011	55
15	A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidis Microbes and Infection ·Peter van Ulsen, Ben Adler, 博之鮫田, Maarten J. Gilbert, Mark van Schilfgaarde, Peter van der Ley, Loek van Alphen, Jan Tommassen	2006	34
16	Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives Vaccine ·Carmen Arigita, J-P Vial, Wim Jiskoot, Martien C. M. Poelen, Wim E. Hennink, Daan J.A. Crommelin, Peter van der Ley, Cécile A. C. M. van, Gideon Kersten	2005	30
17	Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production Cellular Microbiology ·Heli Uronen‐Hansson, Liana Steeghs, Jennifer Allen, Garth Dixon, Mohamed Osman, Peter van der Ley, Simon Y. C. Wong, Robin E. Callard, Nigel Klein	2004	27
18	Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria Journal of Lipid Research ·Tom Sprong, Mihai G. Netea, Peter van der Ley, J Ramilio, Liesbeth Jacobs, Anton F. H. Stalenhoef, J.W.M. van der Meer, Marcel van Deuren	2004	17
19	Immunogenicity of in vitro folded outer membrane protein PorA ofNeisseria meningitidis FEMS Immunology & Medical Microbiology ·Ali Esmaeili Ardekani, Betsy Kuipers, J.W. de Vries, Hans de Cock, Peter van der Ley, Jan Tommassen	2000	20
20	Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine Vaccine ·C C Peeters, H. C. Rümke, Oskar Meuderscheid, In Collaboration With The EPIICAL Consortium, E. Yu. Shelkovnikov, Margje Schuller, Anneke Kuipers, Peter van der Ley, Jan Poolman	1996	130

About Peter van der Ley

Peter van der Ley is a scholar working on Microbiology, Immunology, Epidemiology, Endocrinology and Genetics, having authored 127 papers that have together received 5.3k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (89 papers), Pneumonia and Respiratory Infections (48 papers), Immune Response and Inflammation (45 papers), Bacterial Genetics and Biotechnology (30 papers), RNA and protein synthesis mechanisms (26 papers), Glycosylation and Glycoproteins Research (9 papers), Influenza Virus Research Studies (8 papers) and Bacteriophages and microbial interactions (8 papers). The work is most often cited by research in Microbiology (3.2k citations), Endocrinology (584 citations), Immunology (1.4k citations), Epidemiology (2.2k citations) and Molecular Medicine (279 citations). Peter van der Ley has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jan Tommassen, Jan Poolman, Liana Steeghs, Leo van der Pol, Michiel Stork, Betsy Kuipers, Loek van Alphen, Jan ten Hove, Hendrik Jan Hamstra and Mumtaz Virji. Their work appears in journals such as Infection and Immunity, Vaccine, Journal of Biological Chemistry, Molecular Microbiology and Cellular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact